Choose Boston Business Journal as a preferred news source to see more of our reporting on Google. The deal could mean over ...
BenchSci, which sells AI-powered software for biopharmaceutical research and development (R&D), says it has struck a ...
An announcement from Living Cell Technologies ( ($AU:1AI) ) is now available. Algorae Pharmaceuticals Ltd has launched AlgoraeOS Version 2, a ...
In this webinar, Jae Chang Lim and Hyun Joon Chang will discuss how a cutting-edge artificial intelligence platform is transforming early-stage drug discovery.
A 3-day conference-cum-workshop on “AI-Driven Innovations in Drug Discovery and Agriculture (AI-D2A 2025)” commenced here ...
Tahoe Therapeutics shares the appointments of Wayne Spevak, Ph.D. as VP of Chemistry and Ben Powell, Ph.D. as VP of Drug ...
From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance cellular reprogramming for aging research. The company operates across ...
News-Medical.Net on MSN
Merck partners with Promega to advance 3-D cell dug discovery technologies
Merck, a leading science and technology company, has entered into a partnership with Promega Corporation, a global life ...
Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery ...
InvestorsHub on MSN
Evotec Shares Drop Over 9% as Weakness in Drug Discovery Drags Nine-Month Results
Evotec SE (NASDAQ:EVO) shares plunged 9.3% in premarket trading Wednesday after the German biotech firm reported a decline in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback